HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

ICI 153110

structure given in first source

Also Known As:

4,5-dihydro-6-(2-(pyrid-4-yl)vinyl)-2H-pyridazine-3-one; ICI 153,110; ICI-153110; 3(2H)-Pyridazinone, 4,5-dihydro-6-(2-(4-pyridinyl)ethenyl)-, (E)-

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyridines: 88
    - Dihydropyridines: 214
      - ICI 153110: 3
  - Pyridazines: 11
    - ICI 153110: 3

Related Diseases

1.

09/01/1990 - "We studied 10 patients with chronic heart failure during and after infusion of intravenous (i.v.) ICI 153,110, an investigational peak III PDE inhibitor. "
09/01/1990 - "Acute neurohormonal and hemodynamic response to a new peak III phosphodiesterase inhibitor (ICI 153,110) in patients with chronic heart failure."
05/01/1990 - "ICI 153,110 is an inotropic vasodilator compound intended for the treatment of congestive heart failure. "
01/01/1991 - "The inotropic vasodilator, ICI 153,110, a phosphodiesterase inhibitor intended for the treatment of congestive heart failure, was administered to Alderley Park Wistar-derived rats for periods of up to 182 days. "

Related Drugs and Biologics

1.	Vasodilator Agents (Vasodilators)
2.	Phosphodiesterase Inhibitors